Special articlePost-marketing studies of drug efficacy: Why?☆
References (33)
- et al.
Incidence of ampicillin-resistant Hemophilus influenzae In otitis media
J Pediatr
(1976) - et al.
Moderate sodium restriction and diuretics in the treatment of hypertension
Am Heart J
(1973) - et al.
Post-marketing studies of drug efficacy: how?
Am J Med
(1984) - et al.
The evaluation of new drugs: current Food and Drug Administration regulations and statistical aspects of clinical trials
Arch Intern Med
(1967) - et al.
Drug monitoring
(1977) The discovery of drug induced illness
N Engl J Med
(1977)- et al.
Post-marketing surveillance of new drugs. I. Review of objectives and methodology
J Clin Pharmacol
(1979) - et al.
Drug evaluation after marketing
Ann Intern Med
(1979) - et al.
Postmarketing follow-up
JAMA
(1979) - et al.
Can postmarketing surveillance help to effect optimal drug therapy?
JAMA
(1979)
Ibuprofen (Motrin)-a new drug for arthritis
Med Lett Drugs Ther
(1974)
Effect of dosage regimen on natriuretic response to furosemide
Clin Pharmacol Ther
(1975)
Clonidine (Catapres) for hypertension
Med Lett Drugs Ther
(1975)
Clinical pharmacology of oral antidiabetic agents
N Engl J Med
(1977)
Bronchodilator therapy
N Engl J Med
(1977)
Cited by (0)
- ☆
This work was supported by a grant from the Joint Commission on Prescription Drug Use, by National Institutes of Health Training Grant GM-07546, and by grants from the Charles A. Dana Foundation, the Rockefeller Foundation, and the Andrew W. Mellon Foundation.
- ∗
Current address: Department of Epidemiology, McGill University, 1020 Pine Avenue West, Montreal, Canada H3A 1A2.
Copyright © 1985 Published by Excerpta Medica Inc.